Dallas, TX 1/29/2009 7:30:42 AM
News / Finance

OTCPicks.com Stocks to Watch for Thursday, January 29th SSCC, PSTI, CBAI, QTM

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/microcap.htm today to join this growing community.

Our Stocks to Watch tomorrow include Smurfit-Stone Container Corp. (Nasdaq: SSCC), Pluristem Therapeutics Inc. (Nasdaq: PSTI), Cord Blood America Inc. (OTCBB: CBAI) and Quantum Corp. (NYSE: QTM).

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.

SMURFIT-STONE CONTAINER CORPORATION (NASDAQ: SSCC)

"Up 36.36% on Wednesday"

Smurfit-Stone Container Corporation is one of the industry's leading integrated containerboard and corrugated packaging producers and is one of the world's largest paper recyclers. The company is a member of the World Business Council for Sustainable Development, the Sustainable Forestry Initiative®, and the Chicago Climate Exchange. Smurfit-Stone generated revenue of $7.4 billion in 2007, has led the industry in safety every year since 2001, and conducts its business in compliance with the environmental, health, and safety principles of the American Forest & Paper Association.

PLURISTEM THERAPEUTICS INCORPORATED (NASDAQ: PSTI)

"Up 32.05% on Wednesday"

Pluristem Therapeutics, Inc. engages in the research and development of the mesenchymal and stem cell production technology, and the commercialization of cell therapy products. The company is developing a platform designed to create a functional stem cell production system that can treat severe blood, cardiovascular, autoimmune, and other disorders. It develops PluriX Bioreactor System, which is designed to be a system of stromal cell cultures and substrates that creates an artificial physiological environment where mesenchymal stem cells can grow and reproduce outside of the human body without any use of exogenous biologics or pharmacologicals. The company's principal product, PLX-I is intended to resolve the shortfall of matched tissue for bone marrow transplantation by improving the engraftment of hematopoietic stem cells contained umbilical cord blood. Pluristem's products are derived from mesenchymal stem cells obtained from the placenta and expanded in its proprietary PluriX 3D bioreactor that imitates the natural microstructure of bone marrow and does not require supplemental growth factors, cytokines, or other exogenous materials. The company was founded in 2001 as A.I. Software, Inc. and changed its name to Pluristem Life Systems, Inc. in 2003. Further, it changed its name to Pluristem Therapeutics, Inc. in November 2007. Pluristem Therapeutics is based in Haifa, Israel.

CORD BLOOD AMERICA INCORPORATED (OTCBB: CBAI)

"Up 27.45% on Wednesday"

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.

QUANTUM CORPORATION (NYSE: QTM)

"Up 17.14% on Wednesday"

Quantum Corp. is the leading global storage company specializing in backup, recovery and archive. Combining focused expertise, customer-driven innovation, and platform independence, Quantum provides a comprehensive, integrated range of disk, tape, and software solutions supported by a world-class sales and service organization. This includes the DXi-Series, the first disk backup solutions to extend the power of data deduplication and replication across the distributed enterprise. As a long-standing and trusted partner, the company works closely with a broad network of resellers, OEMs and other suppliers to meet customers' evolving data protection needs.

About OTCPicks.com

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.